Amubarvimab

Tax included
Amubarvimab (BRII-196) is a human IgG1 mAb that bind to non-competing epitopes on the receptor binding domain (RBD) of spike protein, with a KD of 5.88 nM. Amubarvimab can effectively neutralize SARS-CoV-2 variants.
MedChemExpress 
HY-P99435

Data sheet

Size
Multiple sizes
Reactivity
SARS-CoV
Application
COVID-19-anti-virus
CAS
2509447-07-6